Search Results  for '600594.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Guizhou Yibai Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Guizhou Yibai Pharmaceutical Co Ltd (600594-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Guizhou Yi Bai pharmaceutical Co., Ltd. (600594) - Financial Analysis Review

Guizhou Yi Bai pharmaceutical Co., Ltd. (600594) - Financial Analysis Review Summary Guizhou Yi Bai pharmaceutical Co., Ltd. ...

20 Jan 2016 GlobalData 32 $300.00

GuiZhou YiBai Pharmaceutical Co., Ltd.: Downgraded to Average

19 Jan 2016 Sadif Analytics Prime 3 $10.00

Wright Investors Service Comprehensive Report for Guizhou Yibai Pharmaceutical Co., Ltd.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

14 Jan 2016 Wright Reports 56 $75.00

Guizhou Yi Bai pharmaceutical Co., Ltd. (600594) - Financial Analysis Review

Guizhou Yi Bai pharmaceutical Co., Ltd. (600594) - Financial Analysis Review Summary Guizhou Yi Bai pharmaceutical Co., Ltd. ...

11 Dec 2015 GlobalData 34 $300.00

Is The Recovery in GuiZhou YiBai Pharmaceutical Co., Ltd. Too Much, Too Soon?

20 Nov 2015 Sadif Analytics Prime 12 $25.00

Guizhou Yi Bai pharmaceutical Co., Ltd. (600594) - Financial Analysis Review

Guizhou Yi Bai pharmaceutical Co., Ltd. (600594) - Financial Analysis Review Summary Guizhou Yi Bai pharmaceutical Co.,...

18 Sep 2015 GlobalData 25 $125.00

Will GuiZhou YiBai Pharmaceutical Co., Ltd. Deliver Long-Term Returns?

19 Aug 2015 Sadif Analytics Prime 12 $25.00

益佰制药(600594)跟踪研究:员工持股计划完成,提供较强支撑_推荐_张科然_20150701

02 Jul 2015 Huarong Securities Co., Ltd 3 $10.00